COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,627 Articles (22,913 medRxiv, 8,714 bioRxiv)

Most recent first Previous |  Page 830: Articles 8291-8300  | Next

The bacterial lysate Lantigen B reduces the expression of ACE2 on primary oropharyngeal cells
Pizzimenti, C., D'Agostino, A., Pirrello, P., Rinaldi, G., Melioli, G.
10.1101/2022.05.06.490962 — Posted: 2022-05-08
Cell cycle independent role of cyclin D3 in host restriction of SARS-CoV-2 infection
Gupta, R. K., Mlcochova, P.
10.1101/2022.05.07.491022 — Posted: 2022-05-08
Molecular dynamics of spike variants in the locked conformation: RBD interfaces, fatty acid binding and furin cleavage sites.
Shoemark, D. K., Oliveira, A. F., Davidson, A. D., Berger, I., Schaffitzel, C., Mulholland, A. J.
10.1101/2022.05.06.490927 — Posted: 2022-05-08
Reporting Rates for VAERS Death Reports Following COVID-19 Vaccination, December 14, 2020-November 17, 2021
Day, B., Menschik, D., Thompson, D., Jankosky, C., Su, J., Moro, P., Zinderman, C., Welsh, K., Nair, N.
10.1101/2022.05.05.22274695 — Posted: 2022-05-07
"Does a respiratory virus have an ecological niche, and if so, can it be mapped?" Yes and yes.
Stephens, C. R., Gonzalez-Salazar, C., Romero-Martinez, P.
10.1101/2022.05.04.22274675 — Posted: 2022-05-07
Seroprevalence of SARS-CoV-2 Antibodies among vaccinated and non-vaccinated adults in the West Bank: Results of a repeated cross-sectional study
Awartani, F., Qutob, N., Asia, M., Deeb, W.
10.1101/2022.05.06.22274755 — Posted: 2022-05-07
Estimates of excess mortality for the five Nordic countries during the Covid-19 pandemic 2020-2021
Kepp, K. P., Bjork, J. P., Baek, K. T., Lallukka, T.
10.1101/2022.05.07.22274789 — Posted: 2022-05-07
Escape of SARS-CoV-2 variant Omicron to mucosal immunity in vaccinated subjects.
MARTINUZZI, E., BOUTROS, J., BENZAQUEN, J., GLAICHENHAUS, N., HOFMAN, P., MARQUETTE, C. H.
10.1101/2022.05.03.22274517 — Posted: 2022-05-07
Assessing the feasibility of sustaining a 'Zero-COVID' policy in China in the era of highly transmissible variants
Wang, Y., Sun, K., Feng, Z., Yi, L., Wu, Y., Liu, H., Wang, Q., Ajelli, M., Viboud, C., Yu, H.
10.1101/2022.05.07.22274792 — Posted: 2022-05-07
The I-SPY COVID Adaptive Platform Trial for COVID-19 Acute Respiratory Failure: Rationale, Design and Operations
Files, D. C., Matthay, M. A., Calfee, C. S., Aggarwal, N., Asare, A. L., Beitler, J. R., Berger, P. A., Burnham, E. L., Cimino, G., Coleman, M. H., Crippa, A., Discacciati, A., Gandotra, S., Gibbs, K. W., Henderson, P. T., Ittner, C. A. G., Jauregui, A., Khan, K. T., Koff, J. L., Lang, J., LaRose, M., Levitt, J., Lu, R., McKeehan, J. D., Meyer, N. J., Russell, D. W., Thomas, K. W., Eklund, M., Esserman, L. J., Liu, K. D., ISPY COVID Adaptive Platform Trial Network
10.1101/2022.05.05.22274628 — Posted: 2022-05-07

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).